Reply To: “Incidence of Grade 3–4 Liver Injury Under Immune Checkpoints Inhibitors: A Retrospective Study”
Journal of Hepatology- Netherlands
doi 10.1016/j.jhep.2018.09.006
Full Text
Abstract
Available in
Categories
Date
December 1, 2018
Authors
Publisher
Elsevier BV